In late-stage multiple sclerosis, inflammatory cells no longer enter the brain via the bloodstream, but instead the cells arise in memory from local memory cells inside the brain. The findings suggest during the late phases of multiple sclerosis, the disease is occurring entirely inside the brain.
Researchers explore the interplay between the brain and immune system to find new potential targets for treating Alzheimer's disease.
A new study reveals E. gallinarum, a intestinal bacteria, can trigger autoimmune disease. Researchers say the autoimmune activation can be suppressed by a vaccine designed to target the bacteria, and with the help of antibiotics.
Combining a tetanus vaccine with a virus particle may prove effective as a protection against Alzheimer's. The vaccine could also be used to treat allergies and psoriasis, researchers report.
Researchers have implicated serotonin in the pathophysiology of RA.
A new study reports researchers have discovered a way to enhance the effects of immunotherapy to treat glioblastoma.
A new study reports on the processes which amplify neuroinflammation in multiple sclerosis.